logo
Share SHARE
FONT-SIZE Plus   Neg

BMW February Vehicle Sales Rise 4.7% - Update

German premium car-maker Bayerische Motoren Werke AG or BMW Group (BAMXY.PK, BAMXF.PK,BMW.L) Friday reported a 4.7 percent increase in deliveries in February and said it intends to continue the positive development in the year.

In the month of February, the company sold 133,630 BMW, MINI and Rolls-Royce brand automobiles worldwide, higher than 127,638 vehicles sold in the previous year.

"In February the BMW Group achieved another healthy increase in sales and we intend to continue the positive development with exciting new models throughout the year," said Ian Robertson, member of the board of management of BMW AG, Sales and Marketing BMW.

BMW brand's sales in the month increased 7 percent year-over-year to 114,908 vehicles.

Meanwhile, MINI brand delivered 18,527 cars worldwide, down 7.5 percent from the previous year. The launch of MINI Paceman in mid-March is expected to bring further momentum to global sales for the brand, the company said.

In Europe, deliveries increased 6.6 percent, and in Russia, sales jumped 28 percent. In Germany, BMW Group registrations were almost unchanged from last year's level. In Asia, deliveries climbed 6.3 percent.

Year-to-date, the company delivered 256,929 vehicles compared to 239,802 vehicles in the prior year; an increase of 7.1 percent from last year. Year-to-date registrations in Germany increased 4.5 percent from the prior year.

BMW Motorrad sales remained about last year's level in February with a total of 6,847 motorcycles sales. Year-to-date, the company sold 11,665 motorcycles, down 3.4 percent.

On Frankfurt's Xetra, BMW shares are currently trading at 72.67 euros, up 0.65 euros or 0.90 percent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) Friday said its first-quarter profit rose from last year, as revenues increased. However, the company's operating profit dropped hurt by derivative losses and lower railroad revenues. Berkshire is a holding company with a number... Rare commodities are worth more than good is a Chinese adage. And more so when it is in the sought-after drug space. Rare and ultra-rare diseases, also called orphan and ultra-orphan diseases, as the names imply, affect very small numbers of patients. So why the clamor? Shares of steel giant ArcelorMittal were losing around 4 percent in the early morning trading in Amsterdam after the company reported sharp decline in first-quarter EBITDA, a key earnings metric, as sales were weak with lower prices and production. Net loss, however, narrowed from last year. The company also confirmed its forecast for annual EBITDA, which is lower than last year.
comments powered by Disqus
Follow RTT